| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | KDM2A, CXXC-type zinc finger protein 8, FBXL11, JHDM1A, FBL7, KIAA1004, F-box protein FBL7, Lysine-specific demethylase 2A, FBL11, [Histone-H3]-lysine-36 demethylase 1A, F-box protein Lilina, JmjC domain-containing histone demethylation protein 1A, F-box/LRR-repeat protein 11, CXXC8, F-box and leucine-rich repeat protein 11 |
| Clonality | |
| Concentration | |
| Form | Liquid |
| Host | |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target |
Overview
Antibody against KDM2A IP (CXXC-type zinc finger protein 8) for research detection of protein expression and localization.
Target biology
KDM2A is commonly studied as part of epigenetic and chromatin-regulatory machinery that controls transcriptional accessibility through histone modification or chromatin remodeling. These regulators influence differentiation, DNA repair and oncogenic transcriptional programs.
Expected localization
Typically nuclear, often enriched in chromatin-associated complexes.
Research context
This target is frequently studied in the context of Gene Expression & Epigenetics research. Application suitability (e.g., ELISA, IF, IP) is indicated in the specifications; conditions should be optimized by titration. Species reactivity information is provided in the specifications (reported: Human).
Recommended experimental notes
- For IF/ICC, adjust permeabilization (e.g., mild detergent vs stronger conditions) based on expected localization; include secondary-only and isotype controls for background.
- For IP, use gentle lysis to preserve complexes and include an IgG control; validate enrichment by immunoblot or orthogonal detection.
- For ELISA, ensure capture/detection antibody compatibility and run a standard curve; verify sample matrix effects with spike-and-recovery and dilution linearity.
Controls & interpretation
Where possible, confirm specificity using genetic perturbation (KO/KD/CRISPR), peptide competition (if applicable), or an orthogonal readout. Include a negative control sample expected to express low/none of KDM2A IP, and a positive control sample known to express KDM2A IP.
For research use only. Not for diagnostic procedures.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.